Intrinsiqq
Daxor Corporation logo

Daxor Corporation Insider Trading

DXR

Compare
Last 12 months

Insiders bought 27K on the open market and sold nothing.

Net open-market
+27K
6 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 19, 2026

Get an email when DXR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 19
    Robert J Michel
    Chief Financial Officer · bought 1,000 at $8.03
    8K
    3.0% of stake
  • Apr 8
    Michael Richard Feldschuh
    Chief Executive Officer · bought 1,000 at $9.07
    9K
    0.5% of stake
  • Mar 31
    Robert J Michel
    Chief Financial Officer · bought 1,000 at $9.90
    10K
    5.0% of stake
  • Mar 20
    John Jefferies
    Chief Medical Officer · bought 5,941
    —
    34% of stake
  • Dec 9, 2025
    Robert J Michel
    Chief Financial Officer · bought 3,000
    —
    18% of stake
  • Dec 9, 2025
    Jonathan Adam Feldschuh
    Chief Scientific Officer · bought 18,000
    —
    50% of stake
  • Nov 12, 2025
    John Jefferies
    Chief Medical Officer · bought 2,344
    —
    15% of stake
  • Apr 4, 2025
    Michael Richard Feldschuh
    Chief Executive Officer · bought 2,063 at $7.89
    16K
    1.0% of stake
  • Mar 10, 2025
    Robert J Michel
    Chief Financial Officer · bought 1,000 at $8.00
    8K
    6.2% of stake
  • Mar 10, 2025
    Michael Richard Feldschuh
    Chief Executive Officer · bought 3,360 at $7.68
    26K
    1.6% of stake
  • Dec 6, 2024
    Jonathan Adam Feldschuh
    Chief Scientific Officer · bought 32,000
    —
    819% of stake
  • Dec 6, 2024
    Michael Richard Feldschuh
    Chief Executive Officer · bought 45,000
    —
    28% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DXR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Spot a number that looks wrong? Check it in DXR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DXR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.